Aldevron Acquires Nature Technology Corporation
Acquisition combines Aldevron’s leadership in GMP manufacturing with Nature Tech’s portfolio of proprietary technologies.
Aldevron has acquired Nature Technology Corporation (NTC), a developer of innovative and proprietary plasmid constructs and manufacturing solutions that are used in the field of cell and gene therapy. NTC’s nucleic acid-based technologies include NanoplasmidTM, a proprietary vector construct that improves the safety and performance of plasmids and biologics. Aldevron and NTC have complementary service offerings and pairing Aldevron’s world-class manufacturing capabilities with NTC’s innovative solutions will further support our clients and the patients they serve.
For more information about Aldevron’s full suite of offerings, visit www.aldevron.com